Sort
30,917 grants matching “tumor microenvironment”
S1P Lyase in colon cancer
$304,668Julie D Saba · Children'S Hospital & Res Ctr At Oakland · R01 · FY2014 · CA
Oligomannose antigens as conserved immunological targets of Non-Hodgkin lymphomas
$304,653Denong Wang · Sri International · R21 · FY2022 · CA
Stat3 Signaling in Pancreas Cancer
$304,643Nipun B. Merchant · Vanderbilt University · R01 · FY2012 · CA
Activation of Intratumoral pDCs by Tumor Self-DNA Coupled with Anti-microbial
$304,635Michel Gilliet · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
$304,550Bonnie F Sloane · Wayne State University · R01 · FY2012 · CA
Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients
$304,515Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA
Novel Strategies for Hematopoietic Transplantation for Chronic Myeloid Leukemia
$304,509Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
TCR TRANSDUCED CDB T CELLS FOR ADOPTIVE IMMUNOTHERAPY
$304,484Michael I Nishimura · Loyola University Chicago · P01 · FY2014 · CA
Core C: Animal Models
$304,455Stefan Niewiesk · Ohio State University · P01 · FY2015 · CA
CANCAN - Cambridge
$304,426Giulia Biffi · University Of Cambridge · OT2 · FY2022 · CA
Antigen-specific T cells in immunotherapy-associated acute kidney injury
$304,391Naoka Murakami · Washington University · R01 · FY2025 · DK
Integrative and Quantitative Biosciences Accelerated Training Environment
$304,380Peng Qiu · Georgia Institute Of Technology · T32 · FY2025 · GM
Role of Fus1-mediated antitumor CD8T-NK crosstalk in Alzheimer's disease pathology
$304,367Anil Shanker · Meharry Medical College · SC1 · FY2019 · CA
Extracellular Redox Signaling in mammary tumor-fibroblast interactions
$304,324Melissa Lai Tee Teoh · University Of Nebraska Medical Center · R01 · FY2014 · CA
Project 2: Functional Role of the Serine Biosynthesis Pathway in Basal-like Breast Cancer
$304,287Yadi Wu · University Of Kentucky · P20 · FY2019 · GM
Project 2: Functional Role of the Serine Biosynthesis Pathway in Basal-like Breast Cancer
$304,287Yadi Wu · University Of Kentucky · P20 · FY2017 · GM
EphA2 Receptor in Endothelial Cell-Mediated Tumor Progression
$304,278Dana M Brantley-Sieders · Vanderbilt University · R01 · FY2013 · CA
Stat3 Signaling in Pancreas Cancer
$304,278Nipun B. Merchant · Vanderbilt University · R01 · FY2013 · CA
Regulation of immune surveillance by hedgehog signaling in tumor microenvironment
$304,278Jingwu Xie · Indiana University Indianapolis · R01 · FY2013 · CA
Cathepsins in Malignant Progression
$304,248Bonnie F Sloane · Wayne State University · R01 · FY2009 · CA
A phase I trial to assess the safety and immunogenicity of repeated, cluster part
$304,161Ronald D. Alvarez · Johns Hopkins University · P50 · FY2009 · CA
Trajectory and Architecture of Microenvironment-Mediated Resistance in AMLÂ
$304,153Anupriya Agarwal · Oregon Health & Science University · U54 · FY2023 · CA
Trajectory and Architecture of Microenvironment-Mediated Resistance in AMLÂ
$304,153Anupriya Agarwal · Oregon Health & Science University · U54 · FY2025 · CA
Translating Improved Pairing and Timing of Drug Combination Strategies
$304,147Brian J Druker · Oregon Health & Science University · U54 · FY2023 · CA
HYPOXIA AND PRX1 IN FINASTERIDE AND SELENIUM INTERVENTION OF PROSTATE CANCER
$304,113Young-Mee Park · Roswell Park Cancer Institute Corp · P01 · FY2009 · CA